about
Comparative modeling of HGPRT enzyme of L. donovani and binding affinities of different analogs of GMPEstablishment of correlation between in-silico and in-vitro test analysis against Leishmania HGPRT to inhibitorsRole of remote sensing, geographical information system (GIS) and bioinformatics in kala-azar epidemiology.Interaction between Nbp35 and Cfd1 proteins of cytosolic Fe-S cluster assembly reveals a stable complex formation in Entamoeba histolyticaExploring novel KDR inhibitors based on pharmaco-informatics methodology.Elevated Serum ADA Activity as a Marker for Diagnosis and Prognosis of Visceral Leishmaniasis and Post Kala-Azar Dermal Leishmaniasis in Indian Patients.Activity of a novel sulfonamide compound 2-nitro-N-(pyridin-2-ylmethyl)benzenesulfonamide against Leishmania donovani.Analysis of sequence, structure of GAPDH of Leishmania donovani and its interactions.Up-regulation of silent information regulator 2 (Sir2) is associated with amphotericin B resistance in clinical isolates of Leishmania donovani.Computational elucidation of potential antigenic CTL epitopes in Ebola virus.Up regulation of A2B adenosine receptor on monocytes are crucially required for immune pathogenicity in Indian patients exposed to Leishmania donovani.Interaction of frataxin, an iron binding protein, with IscU of Fe-S clusters biogenesis pathway and its upregulation in AmpB resistant Leishmania donovani.Comparative domain modeling of human EGF-like module EMR2 and study of interaction of the fourth domain of EGF with chondroitin 4-sulphate.Understanding the distinguishable structural and functional features in zebrafish TLR3 and TLR22, and their binding modes with fish dsRNA viruses: an exploratory structural model analysis.Leishmania donovani phosphoproteins pp41 and pp29 re-establishes host protective immune response in visceral leishmaniasis.Leishmania donovani: impairment of the cellular immune response against recombinant ornithine decarboxylase protein as a possible evasion strategy of Leishmania in visceral leishmaniasis.Computational elucidation of structural basis for ligand binding with Leishmania donovani adenosine kinase.LeishMicrosatDB: open source database of repeat sequences detected in six fully sequenced Leishmania genomes.Elucidation of novel structural scaffold in rohu TLR2 and its binding site analysis with peptidoglycan, lipoteichoic acid and zymosan ligands, and downstream MyD88 adaptor protein.Computational elucidation, Mutational and Hot spot-based designing of potential inhibitors against human acid-sensing ion channels (hASIC-1a) to treatment of various physiological conditions.Ascorbate peroxidase, a key molecule regulating amphotericin B resistance in clinical isolates of Leishmania donovani.Activation of nucleotide-binding oligomerization domain 1 (NOD1) receptor signaling in Labeo rohita by iE-DAP and identification of ligand-binding key motifs in NOD1 by molecular modeling and docking.Structural insights of rohu TLR3, its binding site analysis with fish reovirus dsRNA, poly I:C and zebrafish TRIF.Structure prediction of gBP21 protein of L. donovani and its molecular interaction.Immunomodulation mediated through Leishmania donovani protein disulfide isomerase by eliciting CD8+ T-cell in cured visceral leishmaniasis subjects and identification of its possible HLA class-1 restricted T-cell epitopes.Identification of MDP (muramyl dipeptide)-binding key domains in NOD2 (nucleotide-binding and oligomerization domain-2) receptor of Labeo rohita.Quantifying the structural requirements for designing newer FLT3 inhibitors.A conformational analysis of mouse Nalp3 domain structures by molecular dynamics simulations, and binding site analysisMolecular Modeling and Ligand-Protein Interaction of N-Protein of Chandipura VirusStructure, evolution and virtual screening of NDM-1 strain from KolkataMolecular docking studies of chloroquine and its derivatives against P23pro-zbd domain of chikungunya virus: Implication in designing of novel therapeutic strategies
P50
Q28259533-D8C506C2-CDAB-4C12-8C50-EB468089B865Q28270383-06820C7A-22E0-48B2-948B-A495937439B8Q30393991-CFD804B9-AC86-4D34-81D4-26EF90FCA786Q34278670-37089E57-EEFB-4A9B-AC3B-D2FBCBFCA579Q34600778-F8A01F4E-0CDE-41F6-AE2B-884ADD16808EQ36019612-2632554F-30CC-4950-AFEE-284E413F44ADQ36951476-705C0A9C-B599-42A0-A6CD-78F69922FCF1Q38323241-BF683F79-332E-4822-BBF4-9DC407B4B206Q39371673-13057A80-3779-4385-8B2A-E1C9CEB674CEQ40135441-C4CB3038-D254-42F4-BAD0-AC842FCFD825Q40839394-57311A89-1DD5-45A1-BADE-D15EB74F674CQ40880764-23710449-633E-4912-A87D-DC38534F0CA8Q41161155-42B99FC7-E772-4A6E-86E7-99BE75725653Q41609652-4C831CFF-9023-4710-A3CF-78E9A85877A8Q41738429-9A843F4B-69D7-4BEA-970A-9D90A87376BCQ41755872-BF3799DD-E50E-4DD5-86C9-CEF56C839AEAQ41854104-6FA72419-3317-4FE0-A57C-96543B46B08CQ42136324-747DAFD3-3ECA-427E-AE22-645F984B11E0Q42181921-16FD4709-01D0-4594-9F23-C1389F3DE057Q42516954-3EE0DC31-8E4E-4099-A8A1-D122BB61A5C6Q42932883-1F494615-C5D2-412B-9A18-CDA5A9C66CDCQ44750133-3EC7597B-CCAB-46D1-8D68-73F95780C35FQ45191032-CB404795-21A8-4EDD-926E-15B3655D342CQ46148191-969BDAAD-3CDA-4631-9891-ABDC68E2263BQ46615573-F391A62E-4AD8-4AD6-A860-98DF37DDE940Q54464443-ED541F96-FF9E-4DFB-8602-2F33574C8135Q54501205-E8F78A79-9E63-4C93-AE23-83E17B522849Q56780435-092C1D92-3904-45CB-B552-7B5938B08DCCQ56780557-30F59B67-B12D-4009-957E-1AD0BCAB85C3Q56780561-56A9B462-E970-4ED9-97B6-78FC3247B3F3Q91921131-97C32246-549E-4DA8-951B-56D4435EABD9
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Manas R. Dikhit
@ast
Manas R. Dikhit
@en
Manas R. Dikhit
@es
Manas R. Dikhit
@nl
Manas R. Dikhit
@sl
type
label
Manas R. Dikhit
@ast
Manas R. Dikhit
@en
Manas R. Dikhit
@es
Manas R. Dikhit
@nl
Manas R. Dikhit
@sl
prefLabel
Manas R. Dikhit
@ast
Manas R. Dikhit
@en
Manas R. Dikhit
@es
Manas R. Dikhit
@nl
Manas R. Dikhit
@sl
P1053
F-1293-2015
P106
P1153
35361400100
P31
P3829
P496
0000-0002-9131-8975